OMX Nordic 40
2.342,92
PKT
+49,12
PKT
+2,14
%
Werbung
Analysen zu OMX Nordic 40-Werten
Datum | Rating | Analyst | |
---|---|---|---|
02.05.25 | Novo Nordisk Buy | UBS AG | |
02.05.25 | Novo Nordisk Market-Perform | Bernstein Research | |
02.05.25 | Novo Nordisk Buy | UBS AG | |
01.05.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
30.04.25 | Novo Nordisk Buy | UBS AG | |
30.04.25 | AstraZeneca Halten | DZ BANK | |
30.04.25 | AstraZeneca Hold | Deutsche Bank AG | |
30.04.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
29.04.25 | AstraZeneca Hold | Jefferies & Company Inc. | |
29.04.25 | AstraZeneca Outperform | Bernstein Research | |
29.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
29.04.25 | Nokia Buy | Deutsche Bank AG | |
29.04.25 | AstraZeneca Buy | UBS AG | |
28.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
28.04.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
28.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
28.04.25 | Novo Nordisk Buy | UBS AG | |
26.04.25 | A.P. Moeller - Maersk A-S (B) Underweight | JP Morgan Chase & Co. | |
25.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
25.04.25 | Volvo (B) Outperform | RBC Capital Markets | |
24.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
24.04.25 | Nokia Market-Perform | Bernstein Research | |
24.04.25 | Volvo (B) Underperform | Bernstein Research | |
24.04.25 | Nokia Neutral | UBS AG | |
24.04.25 | Volvo (B) Buy | Deutsche Bank AG | |
24.04.25 | Nokia Underweight | Barclays Capital | |
24.04.25 | Nokia Hold | Jefferies & Company Inc. | |
23.04.25 | Volvo (B) Buy | UBS AG | |
23.04.25 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
23.04.25 | Ericsson (Telefon L.M.Ericsson) (B) Hold | Deutsche Bank AG | |
23.04.25 | Volvo (B) Buy | Jefferies & Company Inc. | |
23.04.25 | Volvo (B) Outperform | RBC Capital Markets | |
23.04.25 | Volvo (B) Underperform | Bernstein Research | |
22.04.25 | Novo Nordisk Buy | UBS AG | |
22.04.25 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
22.04.25 | Novo Nordisk Buy | Deutsche Bank AG | |
22.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
22.04.25 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
22.04.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
17.04.25 | Novo Nordisk Market-Perform | Bernstein Research |